(Q36457836)

14 August 2017

Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens (English)

1 reference

14 August 2017

Kathryn Thrailkill

1

1 reference

14 August 2017

Gael Cockrell

2

1 reference

14 August 2017

Pippa Simpson

3

1 reference

14 August 2017

Cynthia Moreau

4

1 reference

14 August 2017

John Fowlkes

5

1 reference

14 August 2017

R Clay Bunn

6

1 reference

14 August 2017

1 January 2006

1 reference

Clinical Chemistry and Laboratory Medicine

14 August 2017

1 reference

14 August 2017

44

1 reference

14 August 2017

4

1 reference

14 August 2017

503-504

1 reference

Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242291

Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242291

Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242291

Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242291

The role of matrix metalloproteinase 9 in the pathogenesis of chronic lymphocytic leukaemia

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2242291

Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1515%2FCCLM.2006.090

Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

12 December 2020

Levels of matrix metalloproteinase-1 in patients with and without coronary artery disease and relation to complex and noncomplex coronary plaques

1 reference

12 December 2020

Serum or plasma: What kind of blood sample should be used to measure circulating matrix metalloproteinases and their inhibitors?

1 reference

12 December 2020

Peripheral levels of matrix metalloproteinase-9, interleukin-6, and C-reactive protein are elevated in patients with acute coronary syndromes: correlations with serum troponin I

1 reference

12 December 2020

High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma

1 reference

12 December 2020

Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes

1 reference

12 December 2020

Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease

1 reference

12 December 2020

Identifiers

DOI

10.1515/CCLM.2006.090

1 reference

release_qjvdhoh6d5hhribapggfayvk5y

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qjvdhoh6d5hhribapggfayvk5y

24 November 2022

mapped directly with Wikidata item

1 reference

14 August 2017

PubMed publication ID

16599849

1 reference